Simplex Trading »

Lyell Immunopharma shares owned by Simplex Trading

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Simplex Trading from 13F filings

Historical chart of Simplex Trading investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by Simplex Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by Simplex Trading

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.0k 162 12.35
2025-06-30 $2.0k 298 6.71

More positions owned by Simplex Trading

Spdr S&p 500 Etf Tr Put Put Option
Spdr S&p 500 Etf Tr Call Call Option
Invesco Qqq Tr Put Put Option
Tesla Put Put Option
Nvidia Corporation Put Put Option
Tesla Call Call Option
Invesco Qqq Tr Call Call Option
Nvidia Corporation Call Call Option
Ishares Tr Put Put Option
Ishares Tr Call Call Option
Spdr Gold Tr Call Call Option
Apple Put Put Option
Alphabet Call Call Option
Apple Call Call Option
Meta Platforms Call Call Option

View all positions for Simplex Trading

Top funds holding Lyell Immunopharma

Arch Venture Corp
MWG Management
Foresite Capital Management IV
Vanguard Group
Orland Properties
Almitas Capital
Foresite Capital Management V
venBio Partners
Citadel Advisors
Alphabet
BlackRock
Sc China Holding
Geode Capital Management
Millennium Management
Rbf Capital

View all funds holding Lyell Immunopharma